Covid-19 News and Discussions

@Mr X

Could you do me a favor and rename this thread to "Covid-19 news and discussions" s'il vous plait? The term SARS is very sensitive to Chinese people where SARS brings a lot of bad memories. On top of that, the covid-19 virus is quite distantly related to the SARS virus, only 70 something percent identical. It is 50 percent identical to the MERS virus which has its own subgenus. Considering how distantly related the covid-19 virus is to the SARS virus, it is warranted to assign the covid-19 virus to its own species separate from the SARS virus. The naming of SARS-CoV-2 and placing the covid-19 virus as the same species as the distantly related SARS virus is purely political and it is very opposed by the Chinese government which continues to refer to the covid-19 virus as the novel coronavirus.
 
Last edited:

Severe COVID cases, deaths surging in this Bay Area county​


 

Doctors tracking summer COVID surge in Massachusetts​


 

COVID cases surge in Bay Area as vaccine supply is short​


 

Los Angeles County sees a surge in COVID cases as summer goes into full swing​


 

COVID-19 on the rise nationwide, how to prevent infection​


 

Mississippi sees recent rise in COVID-19 cases​


 

Mississippi sees recent rise in COVID-19 cases​


 

That summer COVID spike​


 

Smartwatch with special sensors reveals early signs of Covid, Flu | World News | WION​


 

ECU Health reports that COVID-19 cases are on the rise​


 

Covid Situation Report: Aug 1, 2024​

Update on Covid providing information on prevalence and hospital admissions for England and its regions. This post is best viewed using the browser or Substack app.​


Bob Hawkins
Aug 01, 2024
24
3
Share

Introduction.

This report is part of a weekly series that summarises the Covid situation in England and its regions.

A reminder that not all of the data previously included in the situation update is now available on a weekly basis. Where relevant, changes to the content and data sources have been noted.

This week's report contains data on weekly Covid hospital admissions from the UKHSA surveillance report, which is now released biweekly. Additionally, it includes case rates from the UKHSA Covid dashboard. The report also provides an update on deaths due to Covid in England and Wales. Finally, there is a summary of some of the key points from a recent paper published in the Lancet that provides a review on some the latest scientific thinking on Long Covid.

Summary.

This week's figures indicate that Covid levels remain high, with test positivity, weekly hospital admissions, and case rates all remaining broadly unchanged at relatively high levels.

In the past two weeks, the positivity rate for Covid has not changed and remains close to the levels seen during the recent winter wave. Positivity rates remain highest in the older age groups.

In the past four weeks, weekly hospital admission rates for Covid have stabilised but at levels approaching the Winter 2023 peak.

The recent increase in daily case rates has levelled off across all regions, with the North East region continuing to experience the highest rate.

Although this year's deaths due to Covid are considerably lower than last year, the recent surge in Covid cases has resulted in an increase in deaths surpassing those recorded in July 2023.

It now seems likely that this summer wave is continuing, indicating that Covid is not a seasonal disease and we are likely to experience further waves as new variants emerge and immunity levels wane.

As always, it’s important to remember that the risk of hospitalisation from Covid infection increases significantly with age and for those immunocompromised. Also Long Covid remains a risk for all as shown by the recent ONS report. Therefore, it is prudent to take appropriate measures such as self-isolating when experiencing Covid symptoms and enhancing ventilation or wearing masks whenever possible.

For those who are interested, a comprehensive review of the evidence in support of wearing masks is available here.


Status of main respiratory diseases in England.

This section starts with the latest available data on positivity rates for primary respiratory infections in England. It is important to understand that positivity differs from prevalence, which refers to the overall percentage of COVID-19 in the general population. Appendix 1 provides a more detailed explanation of the difference and why positivity rates are a useful indicator of trends in Covid infection levels

The chart below displays the test positivity rates for the main respiratory illnesses in England, including Flu, Covid, RSV, and Rhinovirus.


Over the past two weeks, the Covid positivity rate has remained high and was 12.5% for week ending Jul 28 confirming the resurgence of Covid levels in the general population. This is an important reminder that Covid is not currently a seasonal illness and may never become one, so we are likely to experience further waves as new variants emerge and immunity levels wane.

Meanwhile, the flu positivity rate remains significantly lower than that of Covid. Additionally, RSV rates have dropped to very low levels, accompanied by a slight fall in Rhinovirus rates.

The next chart shows the trend for Covid positivity rate by age. Hover your cursor over one of the chart lines to display the positivity rate for all ages. For comparison the grey line shows the positivity rate for all age groups.


The chart clearly indicates that test positivity rates are highest among individuals aged 65 and older although there has been a notable increase in the very youngest age group in the past four weeks. It is important to note that the majority of tests are now conducted on hospital patients, who are disproportionately older since they are more likely to be hospitalised due to Covid.

The final chart in this section shows weekly hospital admissions per 100,000 people in England for the main respiratory diseases.


Consistent with the test positivity rate data, the past two weeks have seen weekly hospital admission rates for Covid stabilise at levels close to those seen during the winter wave of infections. Note that hospital admission data for Flu and RSV is no longer published.

Although age-specific data for hospital admissions are no longer released, earlier statistics on Covid hospital admissions and the current test positivity rates by age indicate that the rise in hospitalizations will primarily impact the over 65 year olds.

It's important to note that while testing policies have been updated from April 1, 2024, the guidelines for testing patients showing Covid symptoms or when a positive result would change the patient's treatment remained unchanged. Consequently, the number of Covid hospital admissions should be a dependable indicator of the virus's prevalence in the community for the period shown in these charts.


Covid hospital admissions and bed occupancy.​

This section gives a more detailed examination of the most recent daily Covid data for hospitals in England.

NHS England stopped the weekly publication of data used to create these dashboards from April 4, 2024 and have moved to a monthly publication schedule. The next update will be on August 8, 2024 covering July Covid hospital admissions and bed occupancy.

Covid case rates​

The UKHSA Covid dashboard continues to publish daily case rates on a weekly basis. As the majority of testing now occurs in hospitals or under medical supervision, these rates should closely align with hospital admissions. However, a comparison of daily case rates and daily admissions shows that this is not the case.

Appendix 2 indicates that although Covid case rates typically reflect the pattern of hospital admissions, there is a notable discrepancy in the magnitude of changes, with admissions experiencing a more pronounced fluctuation than case rates. Therefore, while case rates are helpful in signalling the general trend of Covid within the population, they do not precisely represent the degree of change.

The first chart in this section shows daily case rate per 100,000 individuals.


The chart indicates that the rise in Covid case rates has persisted and continues to be at levels higher than the May peak. However, for the reasons outlined above an in Appendix 2 it is not advisable to compare with the Winter 2023 peak.

The final panel chart in this section shows Covid rates for the regions of England. Hover your cursor over one of the chart lines to display the admission rates for all regions.


The panel charts indicate that the recent increase in case rates across all regions has levelled off, with the North East region still experiencing the highest rate.


Covid Deaths in England and Wales​

The Office of National Statistics (ONS) publishes weekly reports on the number of deaths recorded on death certificates that are due to Covid or where Covid was involved. The data available is for both England and Wales.

The following chart shows a comparison of weekly registered deaths due to Covid in England and Wales for 2023-24, represented in brown, against the previous year, illustrated in blue. The light green shaded area indicates weeks when deaths in 2022-23 were lower than this year, while the light red shaded area denotes weeks when deaths were higher this year. It excludes deaths where Covid was mentioned as a contributing factor on the death certificate.


In the week ending July 19, 2024, there were 165 deaths due to Covid in England and Wales (1.6% of all deaths reported), with an additional 234 deaths where Covid was noted as a contributing factor. This marks the fifth consecutive week where Covid-related deaths have surpassed those of the corresponding weeks in 2023. Despite this recent uptick, the weekly death toll for 2023/24 has been considerably lower than the previous year. Over the 12 months leading up to July 19, 2024, there were 7,354 deaths due to Covid, compared to 15,037 in the preceding 12 months.


Long Covid: a clinical update​

A recent paper published in the Lancet reviewed the state of the science related to Long Covid with a focus on what is currently known about impacts, symptoms, possible mechanisms, and treatments. The following section provides a short summary of the key points presented in the paper. A copy of the paper, which is freely available until the end of September, can be found here.

The paper uses the widely accepted definition of Long Covid which describes it as the persistence or emergence of symptoms 12 weeks following an initial Covid infection, with these symptoms enduring for a minimum of two months without an alternative explanation.

The paper notes that estimates of the incidence of Long Covid following infection vary widely due to different definitions and a lack of diagnostics, However, a recent study from the UK’s Office of National Statistics estimated that the prevalence of Long Covid in the total population in England and Scotland was 1.8%. Further details of the ONS data on Long Covid can be found here.

The paper indicated that while Long Covid could affect anyone, there are multiple factors that increase the risk, which are summarized in the subsequent table.

Image

The paper found that Long Covid is a multi-system condition capable of producing a range of symptoms that may change over time. It observed that individuals with Long Covid often had pre-existing health issues, such as asthma, diabetes, and allergies, which Long Covid could exacerbate. While it is still unclear whether Long Covid is a single disease or multiple conditions, the paper highlighted a consistent and unique pattern in the progression of symptoms—how they emerge, change, persist, intensify, and diminish over time—as they describe below:

'“People with long COVID typically recount an initial acute illness that was either paucisymptomatic (ie, with one or a few symptoms—perhaps cough, fever, and breathlessness) or multisymptomatic (ie, with multiple symptoms, which might include shortness of breath, chest pain, cognitive impairment, loss of smell and taste, profound fatigue, muscle and joint pain, gastrointestinal upset, headache, and rashes),32 although long COVID has also been documented after asymptomatic COVID-19. Following acute COVID-19 infection, people might describe partial or even complete—but temporary—recovery before developing a set of symptoms, either similar to or different from the original illness, which some individuals describe as “strange”, energy-sapping and, in many but not all cases, fluctuating.”
The paper observed that a common symptom in long COVID is fatigue, which becomes worse following physical or mental exertion. Fatigue might be associated with sleep disturbance and blunting of cognitive function making it difficult to work.

The paper also found that “recovery can progress at different rates, and some people experience periods of apparent recovery followed by relapse. The chance of recovery is highest in people who had a less severe acute illness, are in the first 6 months after that illness, and were vaccinated; people whose illness has lasted between 6 months and 2 years are less likely to fully recover.

Although recognising that further research was required, the paper identifies three possible primary pathological mechanisms as follows:

  1. Persistence of virus or its components (proteins S and N) in tissues;
  2. Dysregulated immune response → immunopathology, exhausted T-helper cells, damage to bystander tissue, and auto-immunity; and
  3. Endothelial inflammation and immune-thrombosis
The paper points out that a fuller understanding of these pathological mechanisms will be required to identify effective ‘mechanism based’ treatments.

Finally, the paper summarises various symptoms of Long Covid together with a description of their impact, followed by recommended investigation methods and clinical ways to manage the symptoms .

This section offered just a brief summary of the paper's key points. Should you wish to delve deeper, the complete paper is available for reading here.


In conclusion​

Despite the reduced level of data now published, the available information indicates that the summer wave in Covid levels is not yet over.

Deaths due to Covid are much lower this year although there has been a slight increase in the past month and levels are well above those seen in July 2023.

As always, if you have any comments on this Covid Situation Report or suggestions for topics to cover, please post a message below.


Subscribe



Appendix 1. Test positivity rates and prevalence

Positivity rates are derived from the results of hospital laboratory tests conducted on patients exhibiting symptoms of respiratory diseases. Test positivity is the percentage of patients who test positive for Covid of the total number of patients tested. Since the individuals tested for this measure are not a representative sample of the general population it differs from prevalence, which is derived from a representative sample of the population.

Test positivity rates, while not directly estimating the number of Covid infections in the general population, can be a valuable indicator of the infection trend. The panel chart below compares the weekly test positivity rate among hospital patients with respiratory symptoms to the prevalence of Covid in the general population, as reported in the Winter Infection Survey.


The chart shows that the weekly test positivity rates for patients with symptoms of respiratory infections follows the same pattern as the prevalence for Covid reported by the Winter Infection Survey. Since the Winter Infection Survey is based on a representative sample of the general population this supports using test positivity as a useful proxy for infection trends.


Appendix 2. How reliable are Daily Covid Case Rates?

The UKHSA Covid dashboard continues to publish daily case rates on a weekly basis. As the majority of testing now occurs in hospitals or under medical supervision, these rates should be closely aligned with hospital admissions and the positivity rate of tests.

The first panel chart in this section tests that assumption by comparing the daily case rate per 100,000 individuals, shown in red, with daily hospital admissions for Covid reported by NHS England, depicted in blue.


The chart shows that while Covid case rates generally mirror the pattern of Covid hospital admissions, there is a significant disparity in the scale of changes. The grey shaded areas on each chart highlights the difference between the peak of the winter wave and the recent peak in June. Case rates experienced a 64% decrease, whereas hospital admissions saw a reduction of only 32% between the winter and June peaks.

In conclusion, although case rates are useful for indicating the overall trend of Covid in the population, they do not accurately reflect the extent of change. The likely reason for this is that testing levels have decreased by about a half since January.
 

How successful was the Spring 2024 Booster Campaign?​

This article examines data for the Spring 2024 Covid booster campaign in England to see if any progress was made to improve coverage amongst the eligible groups.​


Bob Hawkins
Jul 26, 2024
13
4
Share

Introduction​

Following the successful mass Covid vaccination campaigns in 2021, the Joint Committee on Vaccination and Immunisation (JCVI) transitioned to a booster strategy targeting the most vulnerable groups.

The booster campaigns have focused on high-risk groups, including the elderly, immunocompromised individuals, and health and social care workers who are more exposed to the virus. These campaigns began in February 2022 and occur in autumn and spring to provide seasonal protection.

Each booster campaign can have different eligibility criteria and the only groups who have been offered all five seasonal boosters are the over 75 year olds and immunosuppressed individuals.

This article follows on from an earlier post covering ‘What can we learn from the Autumn 2023 Covid booster campaign’ which can be accessed here. In that post it was seen that whilst booster coverage in the oldest age groups remained relatively high during Autumn 2023, there was a decline with each subsequent campaign. Moreover, the coverage for booster vaccinations among immunosuppressed individuals was alarmingly low at just over 50%. The post concluded with various recommendations to enhance coverage, which will be discussed in this article.

Summary.​

The Spring 2024 Covid booster campaign ran from April 15 to June 30, 2024. The campaign was exclusively for individuals aged 75 and above, residents of care homes, and those with compromised immune systems. According to NHS England, approximately 7.3 million people qualify for the Spring campaign in England.

In the past, booster coverage among the oldest age groups was high. However, it has diminished with each successive booster campaign and by the close of the Spring 2024 campaign was only 63% — the lowest recorded for any such effort.

Spring 2024 booster coverage for immunosuppressed individuals is concerningly low, reaching just 36% — again the lowest level recorded. This holds especially true for the youngest ages, ethnic minority groups, and the most deprived communities, which exhibit even lower rates.

Coverage for care homes stands at 68%, slightly higher than other eligible groups, yet it has followed a similar trend of falling to their lowest levels.

The continuing fall in vaccination coverage across all eligible groups is concerning, especially as vaccinations are currently the primary method for proactively managing the Covid pandemic in England.


Subscribe



Booster coverage for the elderly.​

This section looks at the elderly which comprise the largest high-risk group eligible for Covid boosters. The following chart, based on data from the recent Winter Infection Survey, shows the risk of being admitted to hospital if you have been infected with Covid by age.


The chart illustrates the increased risk of hospitalisation for individuals aged 75 years and older who contract Covid, which is why age plays a significant role in the booster campaigns. Notably, a significant portion of this group had been vaccinated during the analysis period, suggesting that the risk would have been even higher without the Autumn 2023 booster campaign.

Every booster campaign sets specific and, in some cases, different age criteria for eligibility. This is illustrated in the next chart, which shows age-based coverage throughout the five spring/autumn campaigns which have been run so far.


The chart shows that vaccine uptake increases with age across each booster campaign and is highest in the oldest most vulnerable age group. The data also shows that vaccination coverage is higher among individuals over 75 years old during the autumn campaigns (indicated by green bars) than in the spring campaigns (orange bars).

Finally, there is a noticeable decrease in vaccine coverage in the year following for both autumn and spring campaigns and this led to the recommendation that:

The Spring 2024 booster campaign targeting individuals over 75 years old should address the continuing decline and lower vaccine coverage observed in prior spring campaigns.
Regrettably, the vaccination coverage for the 5.8 million eligible individuals aged 75 and older continued to decline, reaching just 63% by the end of the Spring 2024 booster campaign — the lowest rate of any such effort.


Booster coverage for the Immunosuppressed.​

Individuals who are immunosuppressed may have a reduced capacity to combat infections such as Covid. This is due to a weakened immune system, which can be the result of certain health conditions or the use of medications and treatments that suppress immune function.

Individuals with compromised immune systems are categorized as high risk and have qualified for all Covid booster campaigns. However, comparable data has only been made available for the three most recent campaigns, with the summary data presented in the chart below.


In the previous section, we saw that the spring booster campaigns for the over 75 year olds had lower vaccine coverage than the autumn campaigns. This pattern can also be seen for the immunosuppressed group with coverage at the end of the Spring 2024 campaign falling to 36% from 55% at the close of the Autumn 2023 campaign. However, for all booster campaigns the vaccine coverage was relatively low and it’s worth exploring this in more detail.

The first factor to look at is age. The following table shows vaccine coverage by age at the end of the last three booster campaigns, with the Spring 2024 campaign shown to the right of the table.


The table shows a very clear difference in the vaccine coverage by age for the immunosuppressed. The coverage rises with age and is highest for those 65 years and older. Concerningly, all age groups had there lowest coverage levels at the end of the Spring 2024 booster campaign.

The lower coverage seen for the youngest age group led to the recommendation that:

Greater effort needs to be made to reach the younger immunosuppressed in the Spring 2024 booster campaign.
Worryingly the situation has worsened. Coverage for the youngest age groups is very low and at the end of the Spring 2024 campaign only 3% of the 48,000 eligible 5 to 18 year olds had been vaccinated!

Ethnicity is another area where there is a marked disparity in vaccine coverage as shown in the following table.


Here, all ethnic minorities experience significantly lower coverage, with individuals of Bangladeshi or Pakistani ethnicity having the lowest. Once again, all ethnic groups saw a fall in coverage to there lowest levels at the close of the Spring 2024 booster campaign.

Unsurprisingly, those living in the most deprived areas also had the lowest vaccine coverage in the Spring 2024 booster campaign as shown in the next table.


Several factors contribute to the lower vaccination rates among ethnic minorities and the most deprived. These include vaccine hesitancy due to mistrust, the absence of culturally and linguistically tailored information, and challenges in accessing Covid safe vaccination centres.

This led to the recommendation that:

Efforts must persist in identifying and addressing the factors contributing to low vaccination rates among ethnic minorities and the most deprived communities.
Unfortunately, the latest data shows that no progress has been made in this area.

Finally, the vaccine coverage of immunosuppressed individuals has fallen to its lowest levels for each region, as illustrated in the following table. London's vaccine coverage remains significantly lower when compared to other regions


The likely reasons are London's younger demographic and higher levels of ethnic minorities than other regions.


Booster coverage in care homes​

This final section covers booster coverage in care homes — the third eligible group for the Spring 2024 campaign. Data for care homes is more limited and only covers the Spring 2023 and 2024 campaigns. The following chart compares coverage in care homes at the end of the last two spring booster campaigns.


Coverage for care homes is relatively high compared to the other eligible groups but have followed a similar pattern in falling to there lowest levels.


In conclusion.​

The initial success of the Covid vaccination program has not been maintained in the subsequent booster campaigns. While coverage among the oldest age groups continues to be relatively high, it has diminished with each successive booster campaign.

Booster vaccination coverage for immunosuppressed individuals has also falling with each campaign and is much lower than desired, particularly among the youngest age groups, ethnic minorities, and the most deprived sectors of the population.

The ongoing fall in vaccination coverage across all eligible groups is concerning, considering vaccinations are currently the primary method for managing the Covid pandemic.

As always, if you have any comments or suggestions for topics to cover, please post a message below.v
 

COVID-19 variant KP.3.1.1 becomes dominant in US: See latest CDC data​

Portrait of Ahjané ForbesAhjané Forbes
USA TODAY

The KP.3.1.1 COVID-19 variant is the dominant strain of the virus, the latest projections from the Centers for Disease Control and Prevention (CDC) show.

The agency's Nowcast data tracker, which displays COVID-19 estimates and projections for two-week periods, projects the KP.3.1.1 variant accounting for 27.8% of positive infections, followed by KP.3 at 20.1% in the two-week stretch starting July 21 and ending Aug. 3.

"The KP.3.1.1 variant is very similar to other circulating variants in the United States. All current lineages are descendants of JN.1, which emerged in late 2023," Rosa Norman, a spokesperson at the CDC, previously told USA TODAY.

"At this time, we anticipate that COVID-19 treatments and vaccines will continue to work against all circulating variants. CDC will continue to monitor the severity of variants and will monitor vaccine effectiveness."


Previously, the KP.3.1.1 variant made up 17.7% of cases for the two-week period ending July 20 and KP.3 accounted for 32.9%.

Here is what you need to know about the KP.3.1.1 variant.


How are KP.3 and KP.3.1.1 variants similar?​

The KP.3.1.1 COVID-19 variant is the most prevalent strain at the national, regional and state level for the week ending on July 27, according to the CDC's Nowcast data tracker.

"KP.3.1.1 is a sub-lineage of KP.3," Norman said.

Download USA TODAY's app to get to the heart of newsGen X, Millennials are at greater risk for these types of cancerBallerina Farm, Trad Wives and the epidural conversation we should be havingAttention, chocolate lovers: There may be lead, heavy metals in your favorite candyNearly half of insured Americans get surprise expenses in medical bills, survey finds.How Suni Lee’s health journey changed her gymnastics mindset: ‘This is what I want’
74646424007-getty-images-1725734564.jpg

How are KP.3 and KP.3.1.1 different?​

Norman previously explained that KP.3.1.1 has one change in spike protein.

JN.1, a variant that has been circulating since December 2023, only saw a single change in spike, unlike the KP.3 variant, which is a sub-lineage of the JN.1, Dave Daigle, a spokesperson at the CDC, previously told USA TODAY.



"KP.3.1.1 has one change in the spike protein in comparison to KP.3," Norman said.

COVID-19 symptoms​

The CDC has not said if KP.3 or KP.3.1.1 have their own specific symptoms. However, Norman previously explained that the symptoms associated with KP.3 are similar to those from JN.1. The government agency outlines the basic symptoms of COVID-19 on its website. These symptoms can appear between two and 14 days after exposure to the virus and can range from mild to severe.


These are some of the symptoms of COVID-19:

  • Fever or chills
  • Cough
  • Shortness of breath or difficulty breathing
  • Fatigue
  • Muscle or body aches
  • Headache
  • Loss of taste or smell
  • Sore throat
  • Congestion or runny nose
  • Nausea or vomiting
  • Diarrhea
The CDC said you should seek medical attention if you have the following symptoms:

  • Trouble breathing
  • Persistent pain or pressure in the chest
  • New confusion
  • Inability to wake or stay awake
  • Pale, gray, or blue-colored skin, lips, or nail beds

CDC data shows the COVID-19 test positivity by region​

As of July 30, the CDC saidCOVID-19 infections were growing in 35 states or territories, stable or uncertain in seven and declining in two.

CDC data shows which regions have the lowest and highest COVID-19 positivity rates from July 20 to July 27, 2024.


Note: The CDC organizes positivity rate based on regions, as defined by the U.S. Department of Health and Human Services:

  • Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont.
  • Region 2 :New Jersey, New York, Puerto Rico, and the Virgin Islands.
  • Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and West Virginia.
  • Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee.
  • Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin.
  • Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, and Texas.
  • Region 7: Iowa, Kansas, Missouri, and Nebraska.
  • Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming.
  • Region 9: Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands, and Republic of Palau.
  • Region 10: Alaska, Idaho, Oregon, and Washington.
The test positivity rate displayed in each state represents the positivity rate for that state's entire region.

Can't see the map? Click here to view it.

The CDC data shows COVID-19 test positivity rate was recorded at 16.3% for the week of July 20 to July 27, an absolute change of 2% from the prior week.


Changes in COVID-19 test positivity within a week​

Data collected by the CDC shows the eight Southeast states making up Region 4 had the biggest increase (7.2%) in positive COVID-19 cases from July 20 to July 27, 2024.

Here's the list of states and their regions' changes in COVID-19 positivity for the past week.


  • Region 1 (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont): +0.5%
  • Region 2 (New Jersey, New York, Puerto Rico, and the Virgin Islands): +0.5%
  • Region 3 (Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, and West Virginia): -0.3%
  • Region 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee): +7.2%
  • Region 5 (Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin): +1.8%
  • Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, and Texas): +3.6%
  • Region 7 (Iowa, Kansas, Missouri, and Nebraska): +4.3%
  • Region 8 (Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming): +0.3%
  • Region 9 (Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands, and Republic of Palau): -5.7%
  • Region 10 (Alaska, Idaho, Oregon, and Washington): +2.9%

How can we protect ourselves from KP.3, KP.3.1.1 and other variants?​

The CDC recommends that everyone 6 months old and older get the updated 2024-2025 COVID-19 vaccine. Norman also recommends that the elderly and those who are immunocompromised should get vaccinated in order to protect themselves from COVID-19.
 
Last edited:

Is there a COVID outbreak at the Olympics? At least 10 athletes test positive in one week​

At least ten athletes, including British swimmer Adam Peaty and Australian swimmer Lani Pallister, have tested positive for COVID-19. What safety protocols are at the Olympics?

July 29, 2024, 4:43 PM EDT / Updated Aug. 2, 2024, 4:18 PM EDT / Source: TODAY
By Caroline Kee
At least 10 athletes competing at the 2024 Paris Summer Olympics — including swimmers from multiple countries and five Australian water polo players — have tested positive for COVID-19 in the last week. The uptick in cases has raised questions around the measures in place to stop the spread of COVID at the Olympics.

This year's Games are considered the first post-pandemic Olympics. Unlike the postponed 2020 Summer Olympics in Tokyo, and the 2022 Winter Olympics in Beijing, there are no strict protocols or restrictions around COVID-19 in Paris.


However, COVID-19 is still spreading around the world. The United States is facing a summer wave, and the virus is also spreading in Europe, including in the Olympic Village.

Which Olympians have tested positive for COVID-19?​

Australian swimmer Zac Stubblety-Cook is the latest athlete to test positive for COVID-19, revealing he was "dealing with COVID" in an Instagram post shared shortly after he won the silver medal in the men's 200 meter breaststroke final on Wednesday. "Stubblety-Cook finished a five-day course of antivirals for Covid (Wednesday)," the Australian Olympic Committee tells TODAY.com in an email.

Lani Pallister, another swimmer for Australia, also tested positive for COVID-19 this week. “Relay swimmer Lani Pallister is currently completing the five-day course (of antivirals),” the AOC says.

The 22-year-old withdrew from the women's 1,500 meter freestyle event on Tuesday to “save her energy” for the 4x200 meter freestyle relay on Thursday, Aug. 1, the AOC announced on X. Pallister competed in the highly-anticipated relay, helping win gold for Australia.

“Australian swimmers, as all AOC athletes do, follow established protocols including isolation, social distancing and face masks,” the AOC says.

German decathlete Manuel Eitel took to Instagram to share that he has withdrawn from the Games due to COVID-19. "Today is and will be one of the worst days of my life. Due to COVID infection, I have to cancel my entry for the Paris Olympics for 2024," the 27-year-old wrote, originally in German, in a post on Tuesday, Jul. 30.

Maltese swimmer Sasha Batt also announced her COVID-19 diagnosis on social media. The 19-year-old, who is one of five athletes representing Malta at the Paris Olympics, tested positive for COVID-19 on Tuesday, a media spokesperson for the Maltese Olympic Committee tells TODAY.com in an email.

“She is in good health and is being monitored by the team doctor,” the spokesperson says. Batt was eliminated after competing in the women's 1,500 meter freestyle heat on Tuesday.

British swimmer Adam Peaty tested positive for COVID-19 on July 29, less than 24 hours after winning a silver medal in the men's 100 meter breaststroke final, a spokesperson for Team Great Britain tells TODAY.com via email.

"Adam began feeling unwell on Saturday, ahead of his final. In the hours after the final, his symptoms became worse and he was tested for COVID early on Monday morning. He tested positive at that point," the spokesperson adds.

Peaty is recovering and hopeful to compete in the team relay events later this week, the 29-year-old said in an Instagram post.

"As in any case of illness, the situation is being managed appropriately, with all usual precautions being taken to keep the wider delegation healthy," says Team GB.

Last week, five players on the Australian women's water polo team tested positive for COVID-19, according to a Paris 2024 news release.

“We are treating COVID no differently to other bugs like the flu. This is not Tokyo,” Anna Meares, the chef de mission for the Australian olympic team, said in a press conference last Wednesday.

According to Meares, the protocols for the Australian water polo players who tested positive included wearing masks, isolating from other team members outside of training and avoiding high-volume areas, like the gym.

Have any Team USA Olympians gotten COVID?​

Asked if any Team USA swimmers had tested positive for COVID, a USA Swimming spokesperson tells TODAY.com via email: "We don’t share athlete health information publicly."

Addressing whether USA Swimming is following any COVID safety protocols, the spokesperson says: "We do not have mandatory masking or testing in place. We encourage our athletes to do whatever makes them most comfortable, working with the team doctors."

The U.S. Olympic and Paralympic Committee (USOPC) also tells TODAY.com via email: "We don’t share athlete health information."

Is there a COVID outbreak at the Olympics?​

So far, there are at least 10 confirmed cases of COVID among athletes at the Olympics, which does not meet the threshold to be considered an outbreak, NBC News medical contributor Dr. Kavita Patel, who has expertise in public health and pandemic preparedness, tells TODAY.com.


Patel notes that, based on existing guidelines, 5% of Olympic athletes contracting COVID within a seven-day period would constitute an outbreak.

Dr. William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, tells TODAY.com that he'd call it "a cluster of infections. Some might call it a small outbreak ... but that’s usually a designation (from) local public health investigators.”

However, COVID may be more widespread than the confirmed cases suggest. "The actual number of athletes infected, whether with symptoms or without or very mild symptoms, might be notably higher," Schaffner points out.

"Anytime you have a large congregation of people in one place like this ... you're going to expect that there will be transmission and acquisition of respiratory infections. At the top of the list is COVID, since it's spreading very widely and effectively at the present time," Schaffner says.

What are the COVID protocols at the Olympics?​

There are no mandatory, preventative COVID measures at the Paris Olympics, French newspaper Le Monde reported last week.

A spokesperson for the Paris 2024 press office tells TODAY.com via an email statement Wednesday: “We regularly remind athletes and all other Games stakeholders of the good practices to adopt should they experience any respiratory symptoms: wearing a mask in the presence of others, limiting contacts and washing hands regularly with soap and water or using hand sanitizer. Hand sanitiser stations can be found at all the residential areas and also the restaurant of the Olympic Village.”

“We have a protocol (that) any athlete that has tested positive has to wear a mask and we remind everyone to follow best practices, but in terms of monitoring COVID, cases are quite low in France,” Anne Descamps, Paris 2024 chief communications director said Tuesday, according to Reuters.

Asked by TODAY.com what measures the International Olympics Committee is taking to prevent the spread of COVID, an IOC spokesperson says via email: “Athlete health and safety is of the utmost priority for the IOC and Paris 2024. Paris 2024 is following good practices in managing infectious diseases at the Games.”

Paris 2024 also told Le Monde last week that it’s “closely monitoring (COVID) developments in collaboration with the health ministry and Santé publique France (the French national health agency)” and that it will decide to implement specific COVID measures if necessary “in agreement with the health ministry and the SPF.”

The USOPC tells TODAY.com that it has the following protocols in place to reduce the risk of COVID in its athletes:

"We implemented an infection prevention program prior to the Games (“Don’t let a cold keep you from the gold”) that encouraged athletes to wash their hands, wear face masks when indoors during their travel from the US to Paris, etc.

"At the Games, we encourage those who are feeling sick to come to the sports medicine clinic to be evaluated.

"If they have an infectious disease, we will set them up with the indicated treatment/medications, and provide them with a private room so they don’t have to worry about getting their roommate sick.

"We will help with transportation so they aren’t in a bus with other athletes, and we will deliver their meals.

"We will have them wear a mask anytime they are inside and around other people.

"We will allow them to train and compete as long as they feel up to it."

Patel, who is in Paris at the Olympics, tells TODAY.com she's observed zero COVID protocols and that most staff, including medical personnel, are not wearing masks, though a small number of spectators are. She also says it's not clear how cases are being contained and expressed concern about availability of COVID tests.

The 2024 Olympics, which kicked off last Friday with a star-studded opening ceremony in Paris, involves over 11,000 athletes traveling from over 200 nations, as well as millions of spectators — which experts say are prime conditions for COVID (and other infections) to spread.

However, officials have assured that the Games will not become a superspreader event. "There is no big risk of a cluster," French Health Minister Frédéric Valletoux told broadcaster franceinfo last week. "COVID is here. We've seen a small peak (in cases). But we are far from what we saw in 2020, 2021, 2022," Valletoux added.

Santé Publique France is monitoring the situation closely and has not raised the alert level at this time, Valletoux tweeted on July 25, adding, "We must remain vigilant and respect prevention measures."

The CDC issued the following statement on its website regarding the 2024 Olympics: "Mass gatherings are associated with unique health risks, including an increased risk for respiratory illnesses. If you plan to travel to Paris for these events, make sure you are up to date on routine and recommended vaccines, including for COVID-19."
 

Users who are viewing this thread

Back
Top